AIM ImmunoTech, Inc.
(NYSE Amex Equities : AIM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 4.03%69.701.0%$1071.78m
BIIBBiogen, Inc. 0.02%336.711.5%$665.47m
AMGNAmgen, Inc. 0.29%222.791.3%$550.81m
ILMNIllumina, Inc. -1.50%295.943.5%$414.21m
VRTXVertex Pharmaceuticals, Inc. 0.49%246.291.9%$346.37m
REGNRegeneron Pharmaceuticals, Inc. 1.01%403.152.6%$345.56m
ALXNAlexion Pharmaceuticals, Inc. 0.59%103.142.0%$220.13m
AAgilent Technologies, Inc. 0.85%85.061.6%$165.05m
EXASEXACT Sciences Corp. -2.59%99.9824.0%$144.57m
INCYIncyte Corp. -2.27%80.892.5%$113.92m
SGENSeattle Genetics, Inc. -1.12%117.006.1%$113.16m
BMRNBioMarin Pharmaceutical, Inc. 6.13%95.164.3%$102.95m
MRNAModerna, Inc. -1.67%18.230.0%$98.70m
XLRNAcceleron Pharma, Inc. -0.36%94.516.1%$91.83m
ALNYAlnylam Pharmaceuticals, Inc. -1.57%131.038.7%$91.49m

Company Profile

AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.